Search
Foreskin fibroblast (neonatal)
go.drugbank.com/drugs/DB10770ApprovedDermagraft was introduced in the United Kingdom in October 1997, and several other European countries, as well as New Zealand and Australia. … Dermagraft has only been available in the United States as an investigational device (IDE). Dermagraft for the treatment of diabetic foot ulcers was approved for sale in Canada in 1997.
Hydroxycitronellal
go.drugbank.com/drugs/DB14187ApprovedIt has the smell of lilac, lily, and lily of the valley [A34269]. … Hydroxycitronellal has also been shown to be a dermatologic irritant and allergen, and as a result commercially available products are restricted by the International Fragrance Association (IFRA) to contain
Acylcarnitine (6E,10E)-3-Hydroxydodeca-6,10-dienoylcarnitine
smpdb.ca/view/SMP0124044Metabolic(6E,10E)-3-Hydroxydodeca-6,10-dienoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (6E,10E)-3-hydroxydodeca-6,10-dienoyl-CoA reacts with L-carnitine to form (6E,10E)-3-hydroxydodeca-6,10-dienoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine (4E,7E,10E)-hexadeca-4,7,10-trienoylcarnitine
smpdb.ca/view/SMP0124288Metabolic(4E,7E,10E)-hexadeca-4,7,10-trienoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (4E,7E,10E)-hexadeca-4,7,10-trienoyl-CoA reacts with L-carnitine to form (4E,7E,10E)-hexadeca-4,7,10-trienoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine (4E,7E,10E)-hexadeca-4,7,10-trienedioylcarnitine
smpdb.ca/view/SMP0124292Metabolic(4E,7E,10E)-hexadeca-4,7,10-trienedioylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (4E,7E,10E)-hexadeca-4,7,10-trienedioyl-CoA reacts with L-carnitine to form (4E,7E,10E)-hexadeca-4,7,10-trienedioylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine (10E,15Z)-9,12,13-trihydroxyoctadeca-10,15-dienoylcarnitine
smpdb.ca/view/SMP0124334Metabolic(10E,15Z)-9,12,13-trihydroxyoctadeca-10,15-dienoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (10E,15Z)-9,12,13-trihydroxyoctadeca-10,15-dienoyl-CoA reacts with L-carnitine to form (10E,15Z)-9,12,13-trihydroxyoctadeca-10,15-dienoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine (7Z,10Z,13E)-Tricosa-7,10,13-trienoylcarnitine
smpdb.ca/view/SMP0124422Metabolic(7Z,10Z,13E)-Tricosa-7,10,13-trienoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (7Z,10Z,13E)-tricosa-7,10,13-trienoyl-CoA reacts with L-carnitine to form (7Z,10Z,13E)-tricosa-7,10,13-trienoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreStreptococcus pneumoniae type 33f capsular polysaccharide antigen
go.drugbank.com/drugs/DB10341ApprovedInvestigationalIt is an active immunization for intramuscular or subcutaneous injection against pneumococcal disease such as pneumococcal pneumonia and pneumococcal bacteremia.
Mixtures: PNEUMOVAX 23 0,5 ML ENJEKSIYONLUK COZELTI ICEREN FLAKON, 1 ADETMagnesium Aluminum Silicate
go.drugbank.com/drugs/DB11230ApprovedWithdrawnIt also has antacid properties and is used as a component of some over the counter antacid medications. … It is refined to a powder for use in cosmetic and pharmaceutical applications as an absorbent, anticaking agent, opacifying agent, viscosity-increasing agent, suspending agent, tablet and capsule disintegrant